Vimarsana
Biggest News Aggregation in the World

Page 28 - Peter Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Olson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Olson Today - Breaking & Trending Today

Sage survey of 13,000+ businesses finds strong long-term optimism, but short-term barriers put this confidence in jeopardy - Vimarsana News

Sage survey of 13,000+ businesses finds strong long-term optimism, but short-term barriers put this confidence in jeopardy

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Want to move from customer success hype to action? Start with a maturity model - the Sage Intacct SaaS vertical example - Vimarsana News

Want to move from customer success hype to action? Start with a maturity model - the Sage Intacct SaaS vertical example

The enterprise software industry is overloaded with customer success hype. But I'm on the hunt for inspiring and instructive examples. Here's a standout, via the Sage Intacct SaaS vertical team - complete with new graphics for diginomica readers.

Phillips Distilling Upends Traditional Flavored Whisky Category With Brand Repositioning Of Cult Classic Revel Stoke® - Vimarsana News

Phillips Distilling Upends Traditional Flavored Whisky Category With Brand Repositioning Of Cult Classic Revel Stoke®

/PRNewswire/ -- Phillips Distilling Company, a pioneer in breakthrough flavors and spirits innovation for more than 109 years, today announced Revel Stoke® has...

Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer - Vimarsana News

Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research...

Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer - Vimarsana News

Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research...